Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

UVB light attenuates the systemic immune response in CNS autoimmunity.
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
ONO-4641 Met Primary Endpoint of Phase II Study in Multiple Sclerosis Patients
3D models of human ERα and ERβ complexed with coumestrol.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain. Reply].
The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark.
Connective Tissue and its Growth Factor, CTGF, Distinguish the Morphometric and Molecular Remodeling of the Bladder in a Model of Neurogenic Bladder.
CHMP recommends granting a marketing authorization for Santhera's Raxone® for the treatment of Leber's Hereditary Optic Neuropathy (LHON)
Influence of cigarette smoking on white matter in patients with clinically isolated syndrome as detected by diffusion tensor imaging.
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety.
High dose naltrexone for dyskinesias induced by levodopa.
Recurrence of disease activity after repeated Natalizumab withdrawals.
Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple Sclerosis
Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
Complementary and alternative medicine in multiple sclerosis.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
High dose thiamine improves fatigue in multiple sclerosis.
Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.

Pages